Product Information
LISDEXAMFETAMINE 30 MG TB CHEW is a generic product labeled by Granules Pharmaceuticals Inc., priced at $3.3552 per EA under NDC 70010021601. Its NADAC has been published 71 times since Apr 16, 2025.
FDA first approved this application on Dec 16, 2024. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Granules Pharmaceuticals Inc.NDC
70010021601
Classification
Generic
Dosage Form
TABLET, CHEWABLE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LISDEXAMFETAMINE DIMESYLATEApproval Type
Generic (ANDA)
FDA Application
ANDA219258FDA Approved
12/16/2024
TE Code
AB
On Market Since
12/17/2024
Pharmacological Classes
Price Statistics
The NADAC for LISDEXAMFETAMINE 30 MG TB CHEW has been published 71 times since Apr 16, 2025, and over the history we have for it it has declined 56.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.3552 per EA |
|---|---|
| All-time high | $7.7532 (Apr 16, 2025) |
| All-time low | $3.3552 (Aug 19, 2026) |
| 52-week high | $7.3210 |
| 52-week low | $3.3552 |
| Median price | $6.3569 |
| Average price | $6.0191 |
| Largest weekly change | -17.2% (Jul 22, 2026) |
| Weeks tracked | 71 |
| Tracking since | Apr 16, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LISDEXAMFETAMINE 30 MG TB CHEW?
The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 30 MG TB CHEW, manufactured by Granules Pharmaceuticals Inc., is $3.3552 per EA (NDC 70010021601), effective Aug 19, 2026.
How has the price of LISDEXAMFETAMINE 30 MG TB CHEW changed over time?
Over the history we have for it, the NADAC for LISDEXAMFETAMINE 30 MG TB CHEW has declined 56.7%. It has been tracked across 71 weekly CMS publications since Apr 16, 2025.
What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 30 MG TB CHEW?
Since Apr 16, 2025, the NADAC for LISDEXAMFETAMINE 30 MG TB CHEW has ranged from a low of $3.3552 (Aug 19, 2026) to a high of $7.7532 (Apr 16, 2025), with a median of $6.3569 per EA.
Are there cheaper alternatives to LISDEXAMFETAMINE 30 MG TB CHEW?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 30 MG TB CHEW in a comparable dosage form, but none are currently priced below it.
Who manufactures LISDEXAMFETAMINE 30 MG TB CHEW?
LISDEXAMFETAMINE 30 MG TB CHEW (NDC 70010021601) is labeled by Granules Pharmaceuticals Inc., and CMS classifies it as a generic product.